Higher levels of 3 macular pigments minimize risk of age-related disease.
Ophthalmology Times: December 2020
Study evaluates the impact of surgical procedure on visual outcomes in patients.
A new gene therapy for this patient population targets the ND4 gene mutation.
New options open possibilities for treatment, resulting in better outcomes for patients.
Pandemic forces some to reconsider careers.
A novel ocular corticosteroid is offering hope of quick results for patients.
Check out the latest cartoon!
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Starting from scratch on neovascular age-related macular degeneration
2
Dompé's NAION program selected for FDA Commissioner’s National Priority Voucher Program
3
AAO 2025: Early optogenetic therapy shows promise for patients with inherited retinal diseases
4
Q&A: Insights from Rajesh K. Rajpal, MD, on an incision-free keratoconus therapy
5
.png "Optometry Times"){kind=logo}
